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Tailoring a NICU-Based Tobacco Treatment Program for Mothers 
Who Are Dependent on Opioids
Amanda Fallin-Bennett and Kristin Ashford
Abstract
Objective—To collect formative information to design a tailored tobacco treatment intervention 
for women with newborns treated or evaluated for neonatal abstinence syndrome and to explore 
current tobacco use behaviors and facilitators and barriers to smoking cessation.
Design—Qualitative descriptive study.
Setting—An academic medical center in the southern United States.
Participants—Mothers of newborns who were treated or evaluated for neonatal abstinence 
syndrome at birth within the preceding three months. Women were recruited who were older than 
18 and reported opioid dependence and smoking during pregnancy.
Methods—Participants took part in semi-structured individual interviews that lasted 
approximately one hour. Interviews were professionally transcribed and analyzed in MAXQDA 
using content analysis.
Results—Five themes emerged from the data: Strategizing to Reduce Risk, Desire to Quit 
Smoking in the Future; Holding on to Smoking While Working Through Recovery, Feeling 
Judged by Nurses, and Feeling Supported And Empowered By Nurses. Participants reported 
planning to reduce risk to their newborns by avoiding secondhand and thirdhand smoke exposure. 
Participants wanted to stop smoking but reported many barriers, including multiple life stressors 
compounded by their newborns’ extended stays in the hospital. However, most participants 
described overall positive experiences and the support of health care providers.
Conclusions—Holistic tobacco treatment programs that incorporate stress relief and social 
support and are led by trusted health care providers have the potential to be effective to reduce 
smoking in new mothers with histories of opioid dependence disorders and smoking and whose 
newborns are in the NICU.
Smoking during pregnancy is a leading cause of preventable adverse birth outcomes (U.S. 
Department of Health and Human Services, 2014), including preterm birth (Ion & Bernal, 
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2015), low birth weight, and sudden infant death syndrome (Zhang & Wang, 2013). In 
addition, smoking during the first trimester was associated with a 19% increase in NICU 
admission (Räisänen et al., 2013). Further, the risks of smoking continue beyond the 
perinatal period. Women who smoke were less likely to breastfeed (Weiser et al., 2009), and 
children exposed to secondhand smoke were more likely to have ear and respiratory 
infections and asthma attacks (U.S. Department of Health and Human Services, 2006). 
Exposure to secondhand smoke in the first six months of life was associated with an 
increased risk of hospitalization for serious infection until children are eight years old 
(Kwok et al., 2008).
Smoking cessation during pregnancy is ideal but difficult and not always achieved. In the 
United States, 10.7% of women reported smoking in the third trimester of pregnancy (Tong 
et al., 2013). In addition, 42% of women who successfully stop smoking during pregnancy 
ultimately relapse, and this rate of relapse remained constant over a 10-year period (Rockhill 
et al., 2016). The rates of smoking during pregnancy are even higher in vulnerable groups of 
women, including women with other addictions. Nearly all (approximately 95%) women 
dependent on opioids reported smoking during pregnancy (Chisolm et al., 2013). According 
to the National Survey on Drug Use and Health (2005–2014), 5% of pregnant women in the 
United States reported non-medical prescription opioid use (Kozhimannil, Graves, Levy, & 
Patrick, 2017).
In order to promote long-term cessation for mothers, tobacco treatment and relapse 
prevention interventions are needed in the early postpartum period, particularly for women 
with opioid dependence. The American College of Obstetricians and Gynecologists (2011) 
recommended the 5 A’s approach for smoking cessation in the perinatal period. Holbrook & 
Kaltenbach (2011) found that integrating a six-week 5A’s based tobacco treatment 
intervention into substance use disorder treatment leads to a substantial reduction in 
cigarettes consumed per day among pregnant and parenting opioid dependent women 
However, the small percentage of women who successfully stopped smoking in this program 
indicates the need for a longer, more intensive intervention.
The NICU is a logical place for tailored tobacco treatment support in the postpartum period. 
Newborns exposed to smoke in-utero tend to have longer stays in the NICU. This is 
particularly true for newborns of women with opioid dependency who smoke during 
pregnancy. Smoking during pregnancy increases the risk of neonatal abstinence syndrome 
(NAS; Choo, Huestis, Schroeder, Shin, & Jones, 2004). Neonatal abstinence syndrome is a 
constellation of symptoms experienced by neonates exposed to opioids prenatally; it can 
lead to prolonged hospital stays and pharmacologic treatment with morphine (Kocherlakota, 
2014). Smoking during pregnancy was associated with higher necessary doses of morphine 
and longer hospital stays among infants who were opioid exposed in utero (Jones et al., 
2013). Mothers with infants in the NICU reported an interest in receiving health services in 
this setting, including tobacco cessation treatment (Verbiest, McClain, Stuebe, & Menard, 
2016). Finally, having an infant with a high risk health condition also could serve as a 
teachable moment (Pollak et al., 2010) in which the mother has a high level of interest in 
health behavior change to promote the health of her infant.
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Evidence supports the efficacy of tobacco related interventions delivered in the NICU (King, 
Wooderson, Rees, Neild, & Wright, 2008; Phillips et al., 2012; Stotts et al., 2013). King et 
al. (2008) tested the John Hunter NICU smoking cessation program, which included 
motivational counseling delivered by a clinical nurse consultant; a two-week supply of 
nicotine replacement therapy; educational materials on smoking cessation; enrollment into 
QUIT, a telephone cessation support program; and follow-up services in outpatient care or 
by phone. According to self-report smoking status, 33% of participants successfully stopped 
smoking (King et al., 2008). Further, interventions to promote smoke-free homes among 
mothers of infants in the NICU have demonstrated effectiveness. Stotts et al. (2013) tested 
Baby’s Breath II, an intervention in the NICU to promote smoke-free home policies for 
caregivers that included motivational interviewing sessions (two in the hospital and two in 
the home) paired with the potential for incentives (e.g, prize drawings). Significantly more 
caregivers who participated in the intervention adopted smoke-free homes than those who 
received usual care (64% vs. 20%). Phillips et al. (2012) also tested an innovative 
intervention designed to prevent relapse to smoking and promote breastfeeding among 
mothers of infants in the NICU that was tailored to participants’ life circumstances. They 
designed this dual intervention in part because breastfeeding enhances maternal-infant 
bonding and reduces stress, which reduces risk of relapse to smoking. Results of this 
randomized controlled trial indicated that more women who received the intervention 
remained smoke-free than women in the control group (81% to 46%) at 8 weeks (Phillips et 
al., 2012).
In addition, tobacco treatment interventions tailored for disadvantaged women show 
promise. Stewart et al. (2010) tested a tobacco treatment intervention targeted to women 
living in poverty; they found a decrease in participants’ desire to smoke and number of 
cigarettes smoked per day. The intervention targeted tobacco use but holistically addressed 
barriers to tobacco cessation in the women’s lives by promoting self-efficacy, positive health 
behaviors, support seeking, and building social networks. Although these results are 
promising, no other studies were identified in which researchers examined the effects of 
tobacco intervention delivered in the NICU specifically for women with opioid dependence.
Therefore, the purpose of this study was to collect formative information to design a NICU-
based, tailored, tobacco treatment intervention for women with newborns who were treated 
or evaluated for NAS and to explore current tobacco use behaviors and facilitators and 
barriers to smoking cessation.
Methods
Design and Setting
The University of Kentucky Institutional Review Board approved our study, which was 
based on qualitative description, a methodology used to describe phenomena while staying 
close to the data and using the everyday language of the participants (Sandelowski, 2000). 
Participants were recruited from an academic medical center in the south, from within the 
hospital (e.g, flyers in the NICU waiting room), and from an affiliated medication assisted 
treatment (MAT) clinic for pregnant and newly postpartum women dependent on opioids.
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Sample
Participants were mothers of newborns who were treated or evaluated for NAS at birth 
within the preceding three months. Women who were older than 18 and reported dependence 
on opioids and smoking during pregnancy were recruited from December 2015 through 
April 2016. Exclusion criteria included the inability to read and speak English, serious 
mental illness (e.g., schizophrenia, bipolar disorder with current mania, or suicidal ideation), 
or current incarcerated status.
Procedures
After participating in the informed consent process, participants took part in semi-structured 
individual interviews, typical of qualitative descriptive studies (Sandelowski, 2000). 
Interviews took place in a quiet, private location within the hospital or clinic and lasted 
approximately one hour. To facilitate rapport and trust, the interviews were conducted by a 
certified peer support specialist who was a mother in long-term recovery with years of 
experience in working with women with substance use disorders. Interviews began with the 
specialist asking participants to describe their experiences in the hospital while their 
newborns were treated or evaluated for NAS; probes were used to explore positive and 
negative aspects. To transition into conversations about tobacco use, participants were asked, 
Tell me about your experiences with smoking during pregnancy. Follow-up questions were 
asked about quit attempts, barriers to quit attempts, advice from health care providers, and 
rules regarding smoking in the home. While the interviews were based on a guide, 
participants were also asked follow-up or clarifying questions about unexpected findings that 
arose during the interviews.
After the interview, participants took part in a brief survey to assess demographic (e.g, age, 
race/ethnicity) and tobacco use (e.g, cigarettes smoked per day) characteristics. Women who 
participated in our study received a $25 Walmart gift card. We conducted interviews until 
saturation was reached or no new information emerged. The interviews were voice recorded 
and professionally transcribed. To ensure accuracy, the transcripts were then checked against 
the voice recordings.
Analysis
Each transcript was carefully reviewed several times by multiple team members. Next, we 
developed a codebook based on the transcripts. Codes were selected to capture the major 
concepts, topics, processes, and beliefs represented within the data (Jacoby & Siminoff, 
2008). Consistent with qualitative description (Sandelowski, 2000), transcripts were coded 
using content analysis, were applied to the data using a line by line coding approach, and 
then to facilitate interpretation, data were re-organized into a code report (i.e, all the data 
associated with a particular code were reviewed). Next, the data contained within each case 
report were examined and representative quotations were selected (Jacoby & Siminoff, 
2008). Finally, the data were organized into categories and themes, and an example of this 
process is presented in Table 1. Qualitative coding and data management was conducted 
using MAXQDA. To enhance verification, the first two interviews were coded separately by 
the principal investigator (AFB) and a trained research assistant until we reached 90% 
intercoder agreement. The initial two interviews were then coded to consensus. The trained 
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research assistant coded the remainder of the transcripts. Next, we organized the coded data 
into five overarching themes. To further enhance validity, we provided a thick, rich 
description of the participants’ stories by reporting many detailed direct quotes (Creswell & 
Miller, 2000).
Results
Sample Characteristics
The final sample included 11 women in the postpartum period who were opioid dependent 
and used tobacco use during pregnancy and whose newborns were treated or evaluated for 
NAS in a large academic medical center in the southern United States. Participants identified 
as white, non-Hispanic, and were between the ages of 22 and 36. Four participants were 
married, three were living with partners, one was in a relationship but not living with her 
partner, and four were not currently in relationships. The age of first cigarette for the 
participants ranged from nine to 17 years of age. The participants ranked the importance of 
stopping smoking to them as an average of 8 on a scale of 0–10 and the scores ranged from 
4–10 (with 0 indicating not important at all and 10 indicating the most important goal of 
their life), but they ranked their confidence in quitting within the next month at an average of 
5.5 on a scale of 0–10 with a range of 0–10 (with 0 indicating not confident at all and 10 
indicating 100% confident).
Themes
Five themes emerged from the qualitative data: Strategizing to Reduce Risk, Desire to Quit 
Smoking in the Future, Holding on to Smoking While Working through Recovery, Feeling 
Judged by Nurses, and Feeling Supported and Empowered by Nurses.
Strategizing to Reduce Risk—The majority of participants emphasized planning to 
reduce their child’s risk of harm by avoiding secondhand and thirdhand smoke exposure to 
their newborns, rather than quitting. Participants consistently reported the plan to avoid 
thirdhand smoke exposure. According to one participant, her health care provider advised 
her to “keep like a towel outside to wrap around you…and you can just leave it outside but 
you wrap it…around you when you smoke and then before you come in, just take it off and 
leave it outside.” Participants reported learning about the dangers of thirdhand smoke in 
their prenatal care:
You basically have to take an entire shower [after smoking]…change your clothes. 
And you’re still not going to get it off of you…I’m paranoid. I strip down, wash, 
when I go smoke, I cover up completely as much as I can.
Another explained, “Any time I smoke, I come in, I wash my hands, put hand sanitizer on 
and change my shirt.” On the other hand, another participant described struggling to 
implement a smoke-free home policy:
When we moved into this new place, I said, “I’m going to go outside and I’m going 
to stay in this room, like the living room towards the front door, to smoke.” It didn’t 
last a day. I’m there watching TV; I lit up a cigarette and after that it was like, pfft.
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Other participants restricted smoking to certain areas in the home:
So all of my babies… when they go home, we do not smoke in the house. And then 
whenever they’re like 9 months to a year, we start in the bedroom. And that’s where 
we stay. We don’t smoke throughout the house like that.
Lack of full control over their living situation was one barrier to establishing a smoke-free 
home. One participant stated, “It sucks because I have been; there’s 15 people smoking and I 
can’t keep every one of them from smoking in the house; it’s not my house.”
Desire to Quit Smoking in the Future—Participants reported wanting to stop smoking. 
One participant explained “Smoking is something I really would like to quit doing.” Another 
stated, “It’s not good for me and I need to quit.” Participants were motivated to quit smoking 
by the health of their children and a desire to be around to care for their children. According 
to a participant, “If you’re going to be around for them, you’ve gotta quit smoking and take 
care of yourself…I don’t want to leave her [daughter] anytime soon.” A participant also 
acknowledged that stopping smoking was the only way to fully protect her child, “That’s 
really why I want to quit….Even though I’m not smoking in the house, it’s still on me.” One 
participant reported the desire to stop role modeling smoking for other children in her 
family:
My niece the other day, I’ll never forget it, broke my heart. I was sitting at my 
grandparents’ and she was acting like she was smoking and she’s only 3…she’s 
always like, “Are you going to smoke?” And that’s awful to hear a 3-year-old say 
that. I mean, it kills me.
Holding On To Smoking While Working Through Recovery—Participants reported 
many barriers to smoking cessation, and the primary barrier was stress: “I really want to 
[quit smoking]. Right now [the barrier] is mainly the stress.” Another participant explained, 
“After the baby [was born], I knew I wasn’t going to hurt her with it so I just smoked more 
and it kind of calms me down.” Similarly, another reported:
It kind of calms me down. I don’t think I’m addicted to it. I’m not. But when I get 
stressed out, I like to have a cigarette, you know. Just to sit there and think and just 
have something to do.
Participants reported feeling overwhelmed at the idea of smoking cessation in early stages of 
recovery from opioid dependence. One participant explained that smoking was a low priority 
issue for her, giving her current life circumstance, “I think with quitting everything else, it’s 
like the cigarette, it’s the least thing.” Another stated, “I’ll give up everything else; just leave 
my smoking alone. I’ll give it all up; let me smoke a cigarette.” Another participant reported 
that she was unable to quit smoking during pregnancy while dealing with her opioid 
dependence, but that she was currently ready to stop, “I can’t quit everything like that…not 
all at once. But I’m working on it now, to quit smoking.”
Given the stress of their lives and tackling dual addictions, participants described a desire to 
quit in the future. One participant was waiting, “Until I can get myself lined out, because 
that helps my nerves so much.” Another explained,
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I don’t think I’m addicted to it. I think once I get on my feet, I get us a nice house 
and I get my babies back. And I get a job and a GED…stay on my medication… 
everything’s just going to be into place and I won’t even probably care about it. 
Because I don’t really care about it.
In the hospital environment, participants reported dealing with guilt, unexpected events, and 
logistical barriers which prevented them from staying with or visiting their newborns. Guilt 
emerged as a theme throughout the transcripts. The participants described feelings of guilt 
related to their newborns’ withdrawal symptoms, the NAS scoring process, and NAS. One 
explained,
Just watching her jerk like that…she didn’t ask for none of this. She’s innocent in 
all of it. And it just broke my heart to know that that’s something that’s affecting 
her; it’s hurting her…I know what withdrawals are like. God help her if she feels 
like that.
Another explained, “It’s just an instant guilt trip on you and what you did, and why you did 
it, and like, my whole drug use history kind of just flashed before me, like ‘What have I 
done?’”
Other participants also reported major unexpected events. One participant described learning 
her son would be placed with a foster family:
The day before I thought him and I were getting discharged. They didn’t say a word 
the whole time, just let me believe that we were leaving on Thursday and the night 
before told me I had to leave my visitation with my son because a foster family was 
going to come and do bedside teachings.
Some participants reported logistical barriers to visiting their newborns in the hospital, 
including finding transportation to and from the hospital, places to stay and even food: “My 
car blew up and it’s been hard for me to get back and forth to the clinic.” Another explained, 
“I don’t have transportation. I don’t have friends. I don’t have family.” According to one 
participant, “We just homeless, just staying at the hospital and just my baby going through 
hell and that made me go through hell….trying to take care of my baby and not getting no 
sleep and no food.”
Feeling Judged By Nurses—A few participants reported negative interactions with 
health care providers. A participant reported,
One of them [a nurse] acted like I didn’t deserve to have an IV because I had ruined 
my own veins. That I had ruined my veins and it was awful that they had to struggle 
so hard to find one to get my IV.
Another reported,
She [a nurse] came around the corner and she was like, “Ma’am, you gotta put a 
robe on. You cannot hold that baby, you’ve got an open wound…the doctor said 
you had an open wound like you got shot, and you got a bullet hole through you.” 
And I was sitting there thinking, “You should’ve called me over to the side and 
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asked me these things. Because you really just made me feel like I had a bad 
disease.”
Feeling Supported and Empowered by Nurses—Most participants reported feeling 
supported by the health care team; one felt surprised that “they didn’t treat me any 
differently than anyone else.” Another reported, “I was shocked…I expected, honestly, a 
shitty attitude…but there was no one. There’s never been anyone that’s been nasty about 
anything, never. And that’s mind boggling to me because I’ve never had that experience at a 
hospital.” One explained that the health care providers “make you feel like you are doing the 
right thing…that you’ve done the right thing. That it’s ok to ask for help.” Participants 
reported that the support they received from health care providers made a positive 
difference:
I had a meltdown over [on the] mother/baby [unit] over the tremors…that second 
day, they were really noticeable, you know. And I broke down, I melted. Because 
you know, I’ve done this to this baby, it’s my fault…And the nurse was like, “Don’t 
look at it like that.” And she sit with me for an hour and a half and I cried the entire 
time and she sit with me the entire time, and she cried the whole time.
Another reported, “She [the nurse] was the reason I got through having the baby without 
medicine.”
Discussion
Participants reported a variety of efforts to protect their newborns from secondhand and 
thirdhand smoke; however, some discussed barriers to maintaining smoke-free homes. 
Smoke-free homes have the immediate positive effect for the mother and newborn of 
reduction in secondhand smoke exposure. Smokers living in smoke-free homes have more 
tobacco quit attempts and successfully stop smoking (Mills, Messer, Gilpin, & Pierce, 2009) 
or smoke fewer cigarettes per day (Kegler et al., 2012) than smokers living in homes with 
indoor cigarette smoke. Promoting smoke-free homes as a step toward future cessation is a 
recommended approach to for tailored tobacco treatment for vulnerable groups of women 
(Stewart et al., 2010). A harm reduction approach, such as working toward a smoke-free 
home policy, can be a method to enhance confidence and increase readiness for smoking 
cessation.
However, evidence-based, smoke-free home interventions delivered in the NICU should be 
tailored for women with opioid dependence, a particularly vulnerable group. Several 
participants reported living in housing situations in which they lacked control over the 
smoking policy, which supports previous study findings that disadvantaged women (e.g., 
women living below the federal poverty level) can face many complex obstacles to creating 
smoke-free home environments (Amos, Greaves, Nichter, & Bloch, 2012). Therefore, 
smoke-free home interventions and access to needed social services should be paired with 
tailored treatment support for mothers and their partners (Stewart et al., 2010).
Results of our study suggested that women of low socioeconomic status with substance use 
disorders smoke in part to relieve stress. This is supported by a body of research indicating 
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that disadvantaged women (Flemming, Graham, Heirs, Fox, & Sowden, 2013; Flemming, 
McCaughan, Angus, & Graham, 2015; Howard et al., 2013; Stewart et al., 2011), including 
women dependent on opioids (Fallin, Miller, & Ashford, 2016) report smoking to relieve 
stress. In addition, results of our study complemented previous research findings that some 
women dependent on opioids feel overwhelmed at quitting smoking while receiving 
treatment for their substance use disorder (Fallin et al., 2016). To appropriately tailor a 
tobacco treatment intervention for vulnerable women, it is necessary to first understand the 
link between smoking and stress in their lives and then integrate stress reduction and tobacco 
treatment interventions into prenatal and postpartum care. This supports the results of 
previous studies that indicated that vulnerable women were interested in smoking cessation 
but recognized a need for intense support (e.g., a buddy; Fallin et al., 2016; Stewart et al., 
2011) and assistance to navigate the many barriers to cessation services (e.g., child care; 
Stewart et al., 2011).
In addition to the high levels of stress in their everyday lives, having newborns in the NICU 
was an additional stressor. Other parents of infants in the NICU reported feeling 
overwhelmed and uncertain and described the environment as chaotic (Wraight, McCoy, & 
Meadow, 2015). Results of our study supported a larger body of research that indicates 
individuals with substance use disorders face particular stress in the hospital environment 
from real or perceived stigma and discrimination from health care professionals (Chang, 
Dubbin, & Shim, 2016; Cleveland & Gill, 2013) that could lead to less engagement in their 
care (van Boekel, Brouwers, van Weeghel, & Garretsen, 2013). However, most participants 
in our study reported supportive interactions with health care providers. These positive 
relationships can lay the groundwork for health promotion interventions and future health 
care engagement.
Findings of our study have implications for the development of a NICU-based tobacco 
treatment program for opioid dependent women. Health care providers in the NICU setting 
have a responsibility to the maternal-newborn dyad. Nurses who have developed rapport and 
trusted relationships with mothers with opioid dependence are in a prime position to lead 
tobacco treatment groups in the NICU with a holistic approach that encompasses stress 
reduction, support, and self-efficacy for smoking cessation. Group tobacco treatment 
sessions, held during times when the mothers would be away from the newborns’ bedsides 
(e.g, immediately before or after visiting hours) could serve a dual purpose of also creating a 
peer social support network.
Limitations
There are several limitations of our study. As with all qualitative research, these findings are 
based on self-report, and social desirability bias may have hindered participants from openly 
discussing their tobacco use and/or opioid dependence during their pregnancy and early 
postpartum period. We attempted to mitigate this bias as much as possible by having the 
interviews conducted by a certified peer support specialist with many years of experience 
working with women with substance use disorders. We did not collect specific data on infant 
health outcomes (e.g., NAS severity or gestational age at birth), and it is possible that these 
factors may affect the participants’ motivation to quit smoking. Further, all the participants 
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in our study were recruited from one academic medical center (the NICU waiting area and 
affiliated MAT program for pregnant and postpartum women). The results are from a 
relatively homogenous sample of white women of low socioeconomic status. However, this 
does reflect demographics of the region, as pregnant women dependent on opioids in the 
southern region are less likely than those in other regions to have a high school education or 
health insurance (Verbiest et al., 2016). Finally, our study was conducted in a tobacco 
growing state with high rates of smoking during pregnancy.
Conclusion
Nearly all women who are dependent on opioids smoke during pregnancy (Chisolm et al., 
2013). Smoking adversely affects maternal and child health, and interventions are needed to 
promote smoking cessation in the postpartum period. The goal of our study was to collect 
formative data for a tobacco treatment program in the NICU for mothers who are dependent 
on opioids and who smoke. The participants in our study reported planning to reduce their 
child’s risk by avoiding secondhand and thirdhand smoke exposure. Participants wanted to 
stop smoking, but reported many barriers including multiple life stressors compounded by 
their newborns’ extended stay in the hospital. However, most participants described an 
overall positive experience with the healthcare system, with the support of health care 
providers. Holistic tobacco treatment programs incorporating stress relief and social support 
that are led by trusted healthcare providers have the potential to be effective to reduce 
smoking among new mothers with a history of opioid dependence.
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Three call-outs
1. Tobacco treatment interventions in a NICU setting are promising but have not 
been tested for mothers who are dependent on opioids. (after introduction)
2. Participants wanted to stop smoking but reported many barriers, including 
multiple life stressors compounded by their newborns’ extended stays in the 
hospital.
3. Tobacco treatment programs that incorporate stress relief and social support 
and are led by trusted health care providers could reduce smoking in this high 
risk population.
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Table 1
Example of Data Analysis Process
Raw Data Code Category Theme
“So all of my babies… when they go home, we do not 
smoke in the house. And then whenever they’re like 9 
months to a year, we start in the bedroom. And that’s 
where we stay. We don’t smoke throughout the house like 
that.”
Indoor Smoking (Practices) Plan to protect child 
from secondhand 
smoke
Strategizing to 
Reduce Risk
“Secondhand smoke, like with her [referring to her 
daughter], smoking around her and stuff like that, it can 
cause SIDS.”
Indoor Smoking (Advice from 
Health Care Provider)
“It sucks because I have been, there’s 15 people smoking 
and I can’t keep every one of them from smoking in the 
house; it’s not my house.”
Inability to Enact Smoke-free 
Home Policy
Barriers to enacting a 
smoke-free home 
policy
When we moved into this new place, I said, ‘I’m going to 
go outside and I’m going to stay in this room, like the 
living room towards the front door, to smoke. It didn’t 
last a day. I’m there watching TV; I lit up a cigarette and 
after that it was like, pfft.”
Failed Attempt at Smoke-free 
Policy
“Any time I smoke, I come in, I wash my hands, put hand 
sanitizer on and change my shirt.”
Thirdhand Smoke (Practices) Plan to protect child 
from thirdhand 
smoke
“Keep like a towel outside to wrap around you…and you 
can just leave it outside but you wrap it…around you 
when you smoke and then before you come in, just take it 
off and leave it outside.
Thirdhand Smoke (Advice from 
Health Care Provider)
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